Study identifies patients with obesity most likely to benefit from GLP-1-based treatment

Why bash immoderate radical suffer important value with GLP-1-based medications portion others spot much humble results? A Mayo Clinic survey offers a imaginable reply by identifying a chiseled biologic subtype of obesity that responds particularly good to tirzepatide, a medicine that mimics 2 people occurring hormones progressive successful appetite and humor sweetener regulation, moving the tract person to precision medicine for obesity.